Clinical Trial

Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function

Name: Pharmacokinetics of VC005 Tablets in Subjects With Renal Impairment and Normal Renal Function — clinical trial record (NCT07551570)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Recruiting Phase 1

View on ClinicalTrials.gov →

Summary

This study is a Phase I, single-dose, open-label trial designed to evaluate the pharmacokinetics and safety of a single oral dose of 25 mg VC005 tablets in participants with renal impairment compared to participants with normal renal function.

Protocol Amendment History 1 change

critical Recruitment opened 2026-07-08

Trial Details

NCT Number	NCT07551570
Lead Sponsor	Jiangsu vcare pharmaceutical technology co., LTD
Conditions	Renal Impairment
Enrollment	32 participants
Start Date	2026-05-09
Primary Completion	2026-10-30 (estimated)
Study Completion	2026-10-30 (estimated)
Updated on ClinicalTrials.gov	2026-07-07